home.aspx
 
EVENTS

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...

Biorad Medisys Pvt Ltd

SHARESHARESHARE
Biorad Medisys is a leading global specialty manufacturer of a large portfolio of implants and surgical devices . Full-fledged integrated manufacturing facilities in Pune and Bengaluru, adhering to strict GMP are set up, starting its operations almost a decade ago the company operates under stringent guidelines and certified by ISO 13485/IS0 9001-2008. The facilities boast of state of the art machinery imported from UK, Germany & Japan. The company develops and markets innovative technologies and medical products through its two divisions; Orthovasive and Indovasive which are CE certified and partners with healthcare professionals in enhancing patient care.
SHARESHARESHARE

RELATED NEWS


Only a few months after GlaxoSmithKline acquired Waltham, Mass.-based Tesaro, Tesaro released promising data from its Phase I/II GARNET study of dostarlimab in endometrial cancer. An anti-PD-1 antibody checkpoint inhibitor, many are looking to dostarlimab as being a potential competitor with Merck’s blockbuster Keytruda. Tesaro and GSK presented data from the trial at the 2019 Society for Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer in Honolulu, Hawaii. The ongoin...

READ MORE

Scientists from SRI International and Collaborations Pharmaceuticals in the US have identified a potential new inhibitor, tilorone dihydrochloride, for infection by Ebola virus. The researchers used machine learning methods to find the immunomodulatory drug, which is reported to have demonstrated significant efficacy with 100% survival in a disease model of the virus. Tilorone is currently used in Russia for the treatment of various infections such as influenza, acute respiratory viral infection...

READ MORE

AMSBIO has introduced a range of purified cancer exosome samples to help researchers study the role of exosomes in cancer development and metastasis.By targeted filtration of patient serum using a specific binding method removes protein contaminant to isolate exosome at 95% high purity....

READ MORE

La Jolla Pharmaceutical Company (LJPC) had a good day on the market for Wednesday January 04 as shares jumped 6.61% to close at $19.19. About 172,882 shares traded hands on 1,462 trades for the day, compared with an average daily volume of 129,523 shares out of a total float of 18.25 million. After opening the trading day at $18.01, shares of La Jolla Pharmaceutical Company stayed within a range of $19.74 to $18.01....
/WWW.EQUITIES.COM
READ MORE

Alcami Corporation, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces the formation of a Center of Excellence at its world-class active pharmaceutical ingredient (API) development and manufacturing facility in Germantown, Wisconsin....

READ MORE

Sun Pharma, the world's fifth largest specialty generic pharmaceutical company, has announced the launch of BromSite (bromfenac ophthalmic solution) 0.075% in the US market. A nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery, BromSite will be marketed by Sun Ophthalmics, the company’s branded ophthalmic business division. BromSite is the first branded product launched by the...
PHARMABIZ.COM
READ MORE

EVENTS

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...